Table 1 Baseline Characteristics of APIP Patients Between Training Cohort and Validation Cohort
Variable | Training cohort (n = 128) | Validation cohort (n = 60) | t/Z | p |
|---|---|---|---|---|
Age(years) | 29(22–42) | 29(22–41) | -0.761 | 0.447 |
Gestational weeks | 30.19 ± 4.26 | 30.22 ± 3.07 | -0.053 | 0.958 |
RDW(%) | 14.1(10.9–19.1) | 13.55(11.1–18.2) | -1.001 | 0.317 |
ALT(U/L) | 17.15(6.8-318.5) | 17.85(6.8-300.4) | -0.122 | 0.903 |
Albumin(g/L) | 31.1(23.6–42) | 31.9(26.1–42.1) | -1.856 | 0.063 |
BUN(mmol/L) | 5.35(2.2–18.6) | 6.2(2.5–17.9) | -1.822 | 0.068 |
TG(mmol/L) | 3.58(1.28-131.57) | 3.69(1.6–57.6) | -0.016 | 0.987 |
TC(mmol/L) | 6.22(2.2–32.8) | 5.66(2.68-31) | -0.522 | 0.602 |
Scr(umol/L) | 69(26–282) | 72(27–262) | -0.295 | 0.768 |
Calcium(mmol/L) | 1.95(1.2–2.9) | 1.99(1.25–2.9) | -1.314 | 0.189 |
LDH(U/L) | 342(103–1435) | 340(177–1214) | -0.066 | 0.947 |
IAP(mmHg) | 8.3(5.4–13.7) | 9.35(5.5–13.8) | -0.938 | 0.348 |
NLR | 13.60 ± 3.64 | 14.18 ± 3.35 | -1.045 | 0.298 |